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Spatio-spectral regularization to improve
magnetic resonance spectroscopic imaging
quantification
Andrea Larueloa,b*, Lotfi Chaarib,c, Jean-Yves Tourneretb, Hadj Batatiab,
Soléakhéna Kena,e, Ben Rowlanda, Régis Ferranda and Anne Lapriea,d,e
Magnetic resonance spectroscopic imaging (MRSI) is a non-invasive technique able to provide the spatial distribu-
tion of relevant biochemical compounds commonly used as biomarkers of disease. Information provided by MRSI
can be used as a valuable insight for the diagnosis, treatment and follow-up of several diseases such as cancer or
neurological disorders. Obtaining accurate metabolite concentrations from in vivo MRSI signals is a crucial require-
ment for the clinical utility of this technique. Despite the numerous publications on the topic, accurate quantification
is still a challenging problem due to the low signal-to-noise ratio of the data, overlap of spectral lines and the pres-
ence of nuisance components. We propose a novel quantification method, which alleviates these limitations by
exploiting a spatio-spectral regularization scheme. In contrast to previous methods, the regularization terms are
not expressed directly on the parameters being sought, but on appropriate transformed domains. In order to quan-
tify all signals simultaneously in the MRSI grid, while introducing prior information, a fast proximal optimization al-
gorithm is proposed. Experiments on synthetic MRSI data demonstrate that the error in the estimated metabolite
concentrations is reduced by a mean of 41% with the proposed scheme. Results on in vivo brain MRSI data show
the benefit of the proposed approach, which is able to fit overlapping peaks correctly and to capture metabolites
that are missed by single-voxel methods due to their lower concentrations.
INTRODUCTION
Magnetic resonance spectroscopic imaging (MRSI) is a non-
invasive technique able to provide relevant information on
tumour characteristics, progression and response to treatment
not available from conventional morphological magnetic reso-
nance imaging (MRI) (1,2). It has become a valuable tool for the
examination of human brain tumours, prostate and breast
cancers and several neurological disorders (3,4). Despite the
numerous publications on the subject (5–11), the quantification
of MRSI data is still a challenging problem, due to the low signal-
to-noise ratio (SNR) of MRSI signals and the overlap of spectral
lines. The SNR and chemical shift separation of metabolite peaks in-
crease approximately linearly with the increase of magnetic field.
However, considering the relatively weak magnetic fields used in
clinical practice, a limited chemical shift dispersion often causes
spectral overlap and complicates the separation of metabolites.
The difficulty is higher when there are lesions that produce non-
characteristic spectra and when nuisance signals, such as poorly
suppressed water or lipid signals in 1H-MRSI, distort the spectra
and desirable metabolite signals are almost indistinguishable from
noise due to their low concentration. Therefore, improving the SNR
is a key factor in achieving robust and accurate quantification of
MRSI data. The SNR can be improved by increasing the signal using
higher magnetic field strength. However, the implementation of
MRSI at high fields (7 Tesla (T) and beyond) is still challenging,
owing to technical limitations that may reduce the expected SNR,
such as increased field inhomogeneity (12). In fact, currently clinical
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manufacturers do not support field strengths higher than 3 T. Sig-
nal averaging is a widely used technique to improve the SNR at ac-
quisition time. However, this approach is not feasible because of
long acquisition times. Moreover, physiological motion may lead
to destructive averaging, due to variations in signal phase and
frequency. Methods to increase the SNR at the processing level
have also been proposed (13–15). Unfortunately, most of these
methods rely heavily on spectral constraints, limiting their ability
to capture the spatial variations exhibited by in vivo scans,
especially in the context of lesions. As a consequence, they are of-
ten ineffective in practical applications (16).
Many quantification methods also incorporate techniques to
address the low quality of MRSI signals. A common approach
to improve the robustness of the quantification of MRSI spectra
is the incorporation of prior knowledge for some spectral param-
eters. For example, AMARES (5) allows specification of upper and
lower bounds for frequency, damping and phase. It also allows
imposition of relations (such as differences or ratios) between
individual spectral parameters. Simulations as well as in vivo
experiments confirm the decrease of the Cramér–Rao lower
bound (CRLB) (17) when incorporating prior knowledge in the
quantification process (18). Prior knowledge of the spectral
parameters can also be incorporated by making use of experi-
mentally measured (in vitro) or simulated metabolite profiles
(19,20), as implemented in (7–9). More recently, some quantifica-
tion methods have proposed exploiting not only the spectral but
also the spatial context of MRSI signals by incorporating spatial
priors into the quantification model. An early approach using a
priori spatial information was introduced by Soher et al. (6). In
their iterative method, selected parameter estimates are
updated at each iteration assuming the smoothness of these
parameter distributions. The well-known LCModel (7) also
provides a spatial fitting mode for MRSI data. It first analyzes a
central voxel and then proceeds in the neighbuorhood using
previously fitted voxels for initialization and soft constraints for
new fits. In (11), a Bayesian smoothness prior improving the
fitting of MRSI data is proposed. This method encourages
spatially smooth variations for some selected spectral parame-
ters (frequency, damping and phase). In (10), an iterative
approach combining the spatial prior proposed in (11) with other
methods incorporating spatial information is presented. Spatial
smoothing is desirable, because it is reasonable to expect that
neighbouring pixels will contain similar information. However,
it is well known that spatial smoothing tends to blur the images,
since the edges between different regions may be smoothed
out.
In this article, we propose a novel quantification technique
that benefits from both model-based and regularized quantifica-
tion methods. Spatial and spectral regularization terms are incor-
porated jointly, with the aim of increasing the SNR and
exploiting the neighbouring information along the spatial and
spectral dimensions for a given MRSI voxel. In contrast to previ-
ous methods, this prior knowledge is not imposed directly on
selected spectral parameters but rather on the representation
of the data in the wavelet domain. The method exploits the fact
that the wavelet transform maps white noise in the signal
domain to white noise in the transform domain. Thus, while
signal energy becomes more concentrated into fewer coeffi-
cients in the wavelet domain, noise energy does not. This
property enables the efficient separation of signal from noise.
A number of wavelet-based techniques, including quantification
and denoising, have previously been applied to magnetic
resonance (MR) spectroscopy (21–24). Fast MR spectroscopic
imaging has also been accomplished by the use of wavelets to
enable compression in the spectral and spatial domains (25,26).
To our knowledge, this is the first time that the use of the wave-
let properties together with a spatio-spectral regularization has
been integrated into the quantification algorithm. The hybrid
regularization is able to catch the different nature of the spectral
and spatial dimensions of MRSI data. It is worth noting that the
proposed method can be applied in addition to other types of
prior knowledge (such as the ones mentioned previously). A
quantification solution is formulated for the whole MRSI grid.
However, in contrast to previous approaches, the presented
method is more flexible and less restrictive, allowing the preser-
vation of sharp spatial features. In order to fit all signals in the
MRSI grid simultaneously while introducing spectral–spatial
information, a fast proximal optimization algorithm is proposed
to recover the optimal solution.
THEORY
Signal model
In vivo MRS signals are measured in the time domain and consist
of responses from metabolites (including macromolecules),
water and noise. Theoretically, a measured MRS signal at a
spatial position r∈ {1,…, R} can be modelled by a sum of K
exponentially damped complex sinusoids (27) of M time-domain
data samples:
sr mð Þ ¼
XK
k¼1
arkexp iϕkð Þexp dkmþ 2πif kmð Þ
þbr mð Þ þ wr mð Þ þ nr mð Þ
[1]
where m= 1,…,M. In (1), the amplitude ark is proportional to the
number of nuclei contributing to the spectral component of
frequency fk. The damping factor dk provides information about
the mobility and macromolecular environment of the nucleus, φk
is the phase, br is the baseline, i.e. the contribution from macro-
molecules, wr denotes the water signal and the noise term nr is
assumed to be a circular complex white Gaussian noise.
Recent quantification algorithms impose spectral prior knowl-
edge using metabolite templates (7–9). The MRS signal can
therefore be described as a linear combination of basis functions,
leading to
sr mð Þ¼
XK
k¼1
arkhk mð Þþbr mð Þþwr mð Þþnr mð Þ [2]
where hk denotes a basis function (in the time or frequency
domain) and the amplitudes ark are proportional to the concen-
tration of the respective metabolites. Note that m can refer to
either a temporal or spectral index in (2). The following subsec-
tion introduces the new quantification model investigated in this
study.
Quantification model
In MRS, quantification is the estimation of spectral parameters
from measured data. Signal amplitude (in the time domain) is
[2]
[1]
the main parameter of interest, since it is proportional to the
metabolite concentration. Let S∈ℂM × R be the observed MRSI
signal corresponding to a two-dimensional (2D) slice involving
M spectral points and R spatial positions. Also let A∈ℂ K × R be
the matrix containing the contribution of the K metabolites to
the observed signal at each spatial position r= 1,…, R. According
to (2) and assuming that the water signal and the macromolecu-
lar contribution have been previously filtered, we propose to
estimate the metabolite amplitudes from the following inverse
problem:
S ¼ HAþ N [3]
where
H≜
h1 1ð Þ … hK 1ð Þ
⋮ ⋮ ⋮
h1 Mð Þ … hK Mð Þ
264
375; A≜ a
1 1ð Þ … aR 1ð Þ
⋮ ⋮ ⋮
a1 Kð Þ … aR Kð Þ
264
375
S≜
s1 1ð Þ … sR 1ð Þ
⋮ ⋮ ⋮
s1 Mð Þ … sR Mð Þ
264
375; and N≜ n
1 1ð Þ … nR 1ð Þ
⋮ ⋮ ⋮
n1 Mð Þ … nR Mð Þ
264
375
[4]
For each k=1,…, K, hk= [hk(1),…, hk(M)]
T denotes an element
of the metabolite basis (spectral profile). For a fixed spatial posi-
tion r, ar= [ar(1),…, ar(K)]T is a column vector containing the con-
tributions of the different metabolites to the observed MRS
signal and nr= [nr(1),…, nr(M)]T is an additive complex-valued
Gaussian noise of unknown covariance matrix Ψ. Note here that
the spatial positions have been vectorized so that a 2D slice is
represented by an R-dimensional vector.
METHODS
Classic resolution scheme
Our goal here is to solve the inverse problem (3) in order to ob-
tain an estimate Â based on the observation S, the knowledge of
the basis H and the noise covariance matrix Ψ. A basic solution
to this problem is based on the minimization of the weighted
least-squares criterion:
A^WLS ¼ arg min
A
JWLS Að Þ ¼ arg min
A
jjHA Sjj2Ψ [5]
which leads to
A^WLS ¼ HHΨ1H
 ♯
HHΨ1S [6]
where ()H stands for the transposed complex conjugate, ()♯
stands for the pseudo-inverse and jjjjΨ1 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð ÞHΨ1 ð Þ
q
defines
a norm on ℂ K.
Due to the instability of the covariance matrix or the ill-
conditioning of the metabolite basis H, the inverse problem
(3) is generally ill-posed. In this case, the solution ÂWLS can
be unstable and of poor quality. For this reason, one must
generally resort to regularization (28). Regularization simply
consists of introducing some prior knowledge on the target
solution. This issue has been widely investigated in the MRI lit-
erature during the last decade (29–32). Different priors have
therefore been proposed promoting smoothness or sparsity
of the target solutions, either in the original space or in a
transformed domain.
Spatio-spectral regularization
To the best of our knowledge, all existing methods for regular-
ized MRSI quantitation incorporate spatial smoothness assump-
tions on some spectral parameters such as phase or line width
(10,11). While promoting spatial smoothness for such specific
parameters, no constraint is used for the signal amplitudes. In
this article, we propose to incorporate prior knowledge on the
MRSI data using a different regularization approach. On one
hand, we exploit the sparsity of MR spectra by constraining the
ℓ1 norm of the wavelet transform. On the other hand, we favour
solutions (fits) with few irregularities in the spatial dimension by
penalizing the wavelet coefficients of the MRSI grid at each
frequency band (Fig. 1). The term ‘irregularities’ mostly refers to
the noise and nuisance components typically present in MRSI
data. In fact, in MRSI-acquisition conditions, the noise level is
often similar in magnitude to some metabolite signal levels (like
lactate) and noise interferes with signal identification and deter-
mination of the metabolite amplitudes.
MRSI data might not be strictly sparse with respect to the ℓ0
pseudo-norm, due to the typically low spatial resolution of this
type of data. However, we aim to exploit the fact that MRSI data
can be represented using only a few dominating coefficients in
the wavelet domain, leading to a low ℓ1 norm. This is true for
both spectral and spatial dimensions of the data. Indeed, the
spatio-spectral sparsity of MRSI data has already been used
successfully in compressed sensing imaging approaches (25,26).
This prior knowledge is included in the inversion scheme by
using two regularization terms in the optimality criterion J WLS
in (5). Note that the proposed approach can be easily adapted
to any convex penalization in both spectral and spatial
dimensions.
Regularization terms
At a given spectral frequency m, let us denote by (HA)m∈ℂ R
the 2D complex-valued image of size R=Nr×Nc that results from
reshaping the mth row (R-dimensional vector) of the matrix HA.
We employ a dyadic 2D orthonormal wavelet decomposition
operator T over J1 resolution levels. The coefficient field resulting
from the wavelet decomposition of a target image (HA)m is
defined as ζm ¼ ζma ; ζmo;j
 
o∈O;1≤ j ≤ J1
 
, with o∈ O ¼
0; ; 1f g2∖ 0; ; 0ð Þf g , ζma ¼ ζma;l
 
1≤ l≤ LJ1
and ζmo;j ¼ ζmo;j;l
 
1 ≤ l ≤ Lj
,
where Lj= R× 2
 2j is the number of wavelet coefficients in a
given sub-band at resolution j (by assuming that Nr and Nc are
multiples of 2J
1
). Adopting such a notation, the wavelet coeffi-
cients can be re-indexed so that ζma denotes the approximation
coefficient vector at the resolution level J1, while ζmo;j denotes
the detail coefficient vector at orientation o and resolution level j.
On the other hand, let us denote by (HA)r∈ℂM the rth col-
umn of the matrix M corresponding to the spectrum of size M
[4]
at spatial position r. We denote here by F the dyadic 1D ortho-
normal wavelet decomposition operator over J2 resolution levels.
The coefficient field corresponding to the spectrum (HA)r is then
denoted by ζ r ¼ ra; rd;j
 
1≤ j≤ J2
 
, where the subscripts a and d
denote approximation and detail subbands, respectively.
In order to constrain the solution Â to have few irregularities in
both spatial and spectral dimensions, we propose to introduce
two regularization terms. The first one describes the 2D spatial
prior knowledge about the wavelet coefficients of the target so-
lution. This first regularization term is defined as
g1 Að Þ ¼
XM
m¼1
(XLJ1
l¼1
Φpμa;αa T HAð Þ
mð Þa;l
h i
þ
X
o∈O
XJ1
j¼1
XLj
l¼1
Φp
μjo;α
j
o
T HAð Þmð Þo;j;l
h i) [7]
whereΦpμ;α ξð Þ ¼ α ξ  μj jpp, ∀ ξ ∈ℂ ,μjo∈ℂ, αjo∈ℝþ and p ≥ 1 (and
similarly for μa and αa). Due to the shape parameter p, this regu-
larization term makes a compromise between sparsity (p ∼ 1) and
smoothness (p ∼ 2) of the wavelet coefficients of the 2D image
(HA)m. The second regularization term allows us to reduce high
spectral discontinuities (especially close to the metabolite peaks)
between adjacent frequency bands at a voxel r. This regulariza-
tion is made through the penalization of the wavelet coefficients
of the 1D spectra (HA)r:
g2 Að Þ ¼
XR
r¼1
	XLJ2
l¼1
Φβηa;λa F HAð Þ
rð Þa;l
h i
þ
XJ2
j¼1
XLj
l¼1
Φβ
η jd ;λ
j
d
F HAð Þrð Þd;j;k
h o [8]
where η jd∈ℂ , λ
j
d∈ℝþ and β ≥ 1 (similarly for ηa and λa).
Note that this kind of ℓp regularization has already been used
successfully in sparse MRI reconstruction (31,32).
Optimization procedure
Based on the spatial and spectral regularization terms defined in
(7) and (8) (resp. g1(A) and g2(A)) and accounting for the qua-
dratic data fidelity term, JWLS , the criterion to be optimized
can be written as
J Að Þ ¼ JWLS Að Þ þ g1 Að Þ þ g2 Að Þ [9]
Note here that if, for instance, one wants to perform only
spatial regularization, the spectral regularization term can be
removed by setting λjd ¼ λa ¼ 0 in (8). However, using both
regularizations allows high spectral and spatial discontinuities
to be eliminated.
Since J is strictly convex, the uniqueness of its minimizer is
guaranteed. However, J is not necessarily differentiable, which
makes the use of standard gradient-based algorithms for minimi-
zation impossible. We therefore propose to perform the
Figure 1. MRSI data have a few dominating coefficients in the wavelet domain in the spectral and spatial dimensions. Top left: real part of a MR spec-
trum. Top right: MRSI data set at a specific frequency position (MRSI grid) and its corresponding 2D wavelet transform. Bottom left: normalized histo-
grams showing the values of a MR spectrum (ℓ0 norm) and its corresponding 1D wavelet coefficients. Bottom right: normalized histograms showing the
values of a MRSI grid (at a specific frequency position)and its corresponding 2D wavelet coefficients. Only the detail wavelet coefficients are shown in
both cases.
[7]
[8]
minimization of J in (9) by using the concept of proximity oper-
ators (33), which was found to be fruitful in a number of recent
works on convex optimization (31,34).
Since the cost function in (9) is made up of more than two
non-necessarily differentiable terms, an appropriate solution
for its minimization is the simultaneous direction method of
multipliers algorithm (34). A key advantage of this proximal al-
gorithm is that it can be parallelized while converging to the
global minimum. More details about the optimization proce-
dure using a proximal algorithm can be found in the
Appendix.
MATERIAL
Experiments for synthetic data
In order to evaluate the performance of the proposed method,
different experiments on synthetic data were designed. Simu-
lated MRSI data sets were constructed by combining profiles
from the principal metabolites observed in long echo time brain
MRS: choline (Cho), creatine (Cr), N-acetyl-aspartate (NAA) and
lactate (Lac). Metabolite profiles were obtained from quantum
mechanical simulations of a spin-echo MR experiment using
the jMRUI software package (35). First, N= 50 Monte Carlo simu-
lations of MRSI data sets of size 10 × 10 were performed to mea-
sure the accuracy of the proposed method as a function of SNR.
To this aim, five different levels of white Gaussian noise were
added to a noiseless simulated data set. The SNR in dB of each
signal, S, was computed in the frequency domain as
SNR= 20log10 ∥ Sref ∥ 2/(∥Sref S ∥ 2), where Sref denotes the noise-
less signal. Figure 2 shows examples of spectra for different noise
levels considered in this experiment.
The root-mean-squared error (RMSE) of the estimated ampli-
tudes for each metabolite k was calculated for each voxel r as
RMSEk;r ¼ 1N
XN
n¼1
arefk;r;n  bak;r;n 2
arefk;r;nÞ2

uuuut [10]
where arefk;r;n , âk,r,n are the true and estimated amplitudes of the
kth metabolite at voxel r for the nth simulation, respectively.
For each noise level, the performance of the proposed method
is compared with the performance from a voxel-wise quantifica-
tion method (AQSES (9)) and from AQSES-MRSI (the extension of
AQSES for MRSI data (10,36)). In order to provide an indication of
the gain in accuracy provided by the proposed method, the cor-
responding Cramér–Rao lower bounds (17) of the single-voxel
approach are also shown.
A second experiment was considered in order to check that
the proposed method preserves spatial features. Two MRSI data
sets of size 10 × 10 representing different spatial features were
generated. Both data sets contain a region with healthy-
appearing signals and a region with tumour-like signals. In the
first case there is a sharp transition between the two regions,
while a smoother change is applied for the second data set.
The structural similarity index (SSIM) (37) was estimated for the
amplitude map of each metabolite. This index provides a valu-
able measure of performance over the whole grid for each
metabolite.
For all experiments (for both synthetic and in vivo data), a
Daubechies basis with two vanishing moments over one resolu-
tion level (J1 = 1 and J2 = 1 in (7) and (8), respectively) was consid-
ered. Different types of wavelet families were tested and
Daubechies was shown to be the best suited for this type of data.
The reason to use one resolution level is twofold. On one hand,
no significant improvements were noticed using resolution
levels greater than one (16). In the spatial dimension, this is
due mainly to the typically low spatial resolution of the MRSI
images used in the clinical routine (no bigger than 32 × 32). On
Figure 2. Synthetic MRSI spectra for different noise levels [SNR = -0.5, 2, 4.5, 7, 10] and noiseless ground truth.
the other hand, increasing the number of resolution levels in-
creases the number of regularization parameters to be set, which
could lead to less preciseness in the prior information used for
regularization.
In order to promote sparse solutions in the wavelet domain,
the values of p and β in equations (7) and (8), respectively, are
set to p= β =1 for all experiments. Note that only detail coeffi-
cients were processed. This is equivalent to setting the regulari-
zation parameter to zero for the approximation coefficients.
Regularization parameters were selected manually by testing a
number of values for each MRSI data set. The combination of pa-
rameters providing the best trade-off between spectral SNR and
spatial features preservation was selected. It is worth noticing
that fully autocalibrated approaches may be used to estimate
these parameters automatically directly from the data (38,39).
Experiments for in vivo data
In vivoMRSI data were acquired at Institut Claudius Regaud using
a 1.5 T clinical MR scanner (Siemens Magnetom Avanto) using a
3D chemical shift imaging (CSI) sequence with water suppres-
sion, TE = 135ms, TR =1500ms, 512 free induction decay (FID)
data points, 4 averages, slice thickness 15mm, matrix size
16 × 16, field of view (FOV) 160 × 160 mm, yielding a voxel size
of 10mm × 10mm × 15mm. Data were acquired from a healthy
Figure 4. Mean RMSEk,r of the estimated metabolite amplitudes averaged over all the voxels computed for 50 synthetic MRSI data sets of size 10 × 10
for 5 different noise levels (SNR values are: -0.5, 2, 4.5, 7, 10). The proposed method (SSR) is compared with a voxel-wise quantification method (AQSES)
and with a quantification method dedicated to MRSI data (AQSES-MRSI). The averaged RMSEk,r of the proposed method when only the spectral term
(SSR-Spectro) or only the spatial term (SSR-Spatial) are considered are also displayed.
Figure 3. RMSEk,r of the estimated metabolite amplitudes averaged over all metabolites and all voxels computed for 50 synthetic MRSI data sets of size
10 × 10 for five different noise levels (SNR values are: -0.5, 2, 4.5, 7, 10). The proposed method (SSR) is compared with a voxel-wise quantification method
(AQSES) and with a quantification method dedicated to MRSI data (AQSES-MRSI). The averaged RMSEk,r values of the proposed method when only the
spectral term (SSR-Spectro) or only the spatial term (SSR-Spatial) are considered are also displayed. The CRLBs shown were computed from AQSES.
volunteer and from two patients with diagnosed Glioblastoma
multiforme included in a prospective clinical trial.
Note that an estimation of the noise covariance matrix Ψ has
been obtained from a signal (and artifact)-free part of the MRSI
spectra for in vivo data. Preprocessing applied to in vivoMRSI sig-
nals includes residual water suppression (using the Hankel
singular-value decomposition (HSVD) algorithm (40)), frequency
correction and standard polynomial baseline correction. For the
quantification of in vivo data, a metabolite basis set containing
Cho, Cr, NAA and Lac was considered. The choice of this basis
set was based on the fact that these metabolites are the most
visible in long echo time spectra.
The robustness of the proposed method was tested on in vivo
data to check whether the results are consistent with real condi-
tions. Metabolite maps obtained using the proposed method
were compared with maps obtained using voxel-wise quantifica-
tion methods (AQSES (9) and QUEST (8)) and the spatially
constrained approach AQSES-MRSI (10,36)). Regularization pa-
rameters were selected manually using a grid-search strategy
as described in the subsection ‘Experiments for synthetic data’.
The SNR for in vivo spectra was computed in the frequency do-
main as SNR= I/σ, where I denotes the height of the NAA peak
in the real spectrum and σ the standard deviation of the noise
(measured in a signal-free region of the spectrum) (41).
RESULTS
Experiments for synthetic data
Monte Carlo experiments
Figure 3 compares the estimation error of the proposed method,
referred to as spatio-spectral regularization (SSR), with the voxel-
wise quantification method AQSES (9) and AQSES-MRSI (10). The
Figure 6. RMSEk,r of the estimated metabolite amplitudes obtained with the proposed method (SSR) and with AQSES-MRSI for 50 synthetic MRSI data
sets of size 10 × 10 at SNR = 4.5. Each point corresponds to one voxel of the MRSI grid.
Figure 5. Mean SNR values computed for 50 synthetic MRSI data sets of size 10 × 10 for five different noise levels (SNR values are: -0.5, 2, 4.5, 7, 10). The
error bars indicate the mean RMSEk,r of the estimated metabolite amplitudes averaged over all metabolites and all voxels.
estimation error is measured as RMSEk,r averaged over all me-
tabolites and all voxels. The increase in accuracy due to the in-
corporation of the spatial–spectral prior (in the proposed
method) is clearly observed. The errors of the proposed
method when only one of the regularization terms is consid-
ered, referred to as SSR-Spatial (only the spatial regularization
term is used) and SSR-Spectro (only the spectral regularization
term is used), are also displayed. In the same figure (Fig. 3), the
errors in the metabolite amplitudes estimated with each
method are also compared with the CRLB obtained from the
individual voxel approach. SSR provides the best results for
all noise levels, reducing the error by a mean of 41% from
24% to 54% depending on the noise level. This difference in
accuracy can be observed clearly and is even below the CRLB
in some cases. A similar analysis is shown in Figure 4, where
the mean RMSEk,r averaged over all voxels is shown for each
individual metabolite.
Figure 5 shows the quality of the fit (measured by the SNR) for
each method for different noise levels. The curves show the SNR
of the fits, i.e. how close each fitted model is to the ground-truth
signal. The error bars represent the mean RMSEk,r of the esti-
mated metabolite amplitudes averaged over all metabolites
and all voxels at each noise level. Figure 6 shows the scatter plots
of RMSEk,r of the metabolite amplitudes at each voxel. Each point
corresponds to a given voxel. In most voxels, the proposed
method yields lower errors for the metabolite amplitudes com-
pared with the AQSES-MRSI method.
Sharp/smooth edges
Figure 7 presents the results obtained for a synthetic data set
where the border between the regions of healthy and abnormal
spectra is a sharp edge. The first row shows the ground truth for
the amplitudes of NAA, Cr, Cho and Lac. The following rows
show the solutions obtained from three different approaches
and their differences from the ground truth. More precisely, the
second row shows the results using the single-voxel approach
AQSES, the third row shows the results using AQSES-MRSI,
the fourth row shows the proposed spectral–spatial prior (SSR)
and the last three rows show the differences between the
estimated concentrations and the ground truth. The differences
are measured as the percentage with respect to the maximum
ground-truth value for each metabolite. The same experiment
was performed for a simulated data set where the border
between healthy and abnormal tissues is represented by a
smoother edge. Results are shown in Figure 8.
Figure 7. Synthetic MRSI data set containing two regions associated
with healthy and tumour-like signals separated by a sharp edge. From
top to bottom: true metabolite concentrations, estimated metabolite
concentrations using AQSES, AQSES-MRSI and SSR and the difference (er-
ror) between the true metabolite concentrations and the concentrations
estimated using AQSES, AQSES-MRSI and SSR. Errors are measured as a
percentage with respect to the maximum ground-truth value for each
metabolite.
Figure 8. Synthetic MRSI data set containing a region with healthy-
appearing signals and a region with tumour-like signals separated by a
smooth edge. From top to bottom: true metabolite concentrations, esti-
mated metabolite concentrations using AQSES, AQSES-MRSI and SSR and
the difference (error) between the true metabolite concentrations and
the concentrations estimated using AQSES, AQSES-MRSI and SSR. Errors
are measured as a percentage with respect to the maximum ground-
truth value for each metabolite.
Tables 1 and 2 show the SSIM values for the metabolite maps
in Figures 7 and 8, respectively. These values offer an objective
and quantitative measure of the accuracy of the metabolic maps
obtained with the different methods.
In vivo data
We analyze the performance of our method further for in vivo
MRSI data. By analyzing these maps, we can obtain a fast
visual inspection of the performance of the method. In
Figure 9, the metabolite maps depict the presence of NAA,
Cho and Cr as expected in healthy tissue. For the operated
GBM patient (Fig. 10), the Lac map presents a spatial distribu-
tion that matches with the surgical cavity. The presence of Lac
is often observed after surgery and can be linked to the post-
operative reorganization of the tissue. The Cho map presents
higher concentrations in correspondence with the contrast-
enhancing bud of the anterior part of the lesion, suggesting
higher cellular proliferation in this area. For the non-operated
GBM patient (Fig. 11), the NAA map presents lower concentra-
tions spatially matching the centre of the contrast-
enhancement area and the necrosis that can be seen on the
T1 -weighted post-gadolinium injected MR image. The Cho
map shows high concentrations corresponding to the anterior
left part of the contrast-enhancing lesion. The elevated pres-
ence of Cho, together with the collapse of NAA, suggests a
metabolically active tumour region. The Lac map shows higher
concentration in the anterior left part of the tumour, suggest-
ing the presence of anaerobic metabolism in this area and em-
phasizing the heterogeneous aspect of the tumour.
Figure 12 shows nine adjacent voxels from a patient with a
brain tumour and the corresponding fits from AQSES, AQSES-
MRSI and SSR.
Regarding the computational cost, SSR is quite efficient. The
computation time depends on the size of the MRSI grid, the
samples of the spectra and the level of noise. For the in vivo
cases presented in this study, the computation times for process-
ing the whole image were between 50 and 90 s. The experiments
were performed on a 64-bit 1.8 GHz i7-4500U architecture with a
Table 2. SSIM values for each metabolite amplitude map in
Figure 8
SSIM AQSES AQSES-MRSI SSR
NAA 0.83 0.94 0.98
Cr 0.61 0.87 0.90
Cho 0.78 0.92 0.95
Lac 0.41 0.55 0.69
Table 1. SSIM values for each metabolite amplitude map in
Figure 7
SSIM AQSES AQSES-MRSI SSR
NAA 0.69 0.87 0.91
Cr 0.59 0.68 0.78
Cho 0.78 0.91 0.94
Lac 0.20 0.27 0.36
Figure 9. In vivo 3D MRSI acquisition on a healthy volunteer located in the central hemispheric right part of the brain. Metabolite maps of NAA, Cr and
Cho are presented, from top to bottom respectively, using QUEST, AQSES, AQSES-MRSI and SSR.
Figure 10. In vivo 3D MRSI acquisition on a resected Glioblastoma multiforme patient with a left parietal lesion associated with a thin peripheral
contrast-enhancement. Metabolite maps of NAA, Cr, Cho and Lac are presented, from top to bottom respectively, using QUEST, AQSES, AQSES-MRSI
and SSR.
Figure 11. In vivo 3D MRSI acquisition on a biopsied Glioblastoma multiforme patient presenting a central hemispheric right lesion with a mass effect
on the right lateral ventricle and a deviation of the structures through the left of the median line. Metabolite maps of NAA, Cr, Cho and Lac are pre-
sented, from top to bottom respectively, using QUEST, AQSES, AQSES-MRSI and SSR.
Matlab implementation (R2013a). The convexity of the objective
function guarantees convergence to a global minimum.
DISCUSSION
In order to apply the MRSI technique to routine clinical practice,
it is important to maximize the accuracy and robustness of the
quantification. Additionally, both processing time and technique
subjectivity should be minimized by, for example, automation.
The use of regularization techniques has been proved to be a
powerful approach to achieve these objectives. We have pre-
sented here a quantification method based on a combined
spatio-spectral regularization scheme. In contrast to previous
methods, the regularization terms are expressed in the wavelet
domain. The use of a combined spatio-spectral regularization
scheme in a transformed domain allows the method to explore
other types of prior knowledge, going beyond the conventional
assumption of spatial smoothness. The benefits of imposing
appropriate constraints for both spectral and spatial dimensions
of MRSI data have been presented in this article.
Experiments with synthetic data show that the proposed
method increases the accuracy and the robustness of the quan-
tification against noise (Fig. 3). The presented spectral–spatial
prior prevents the quantification algorithm from moving away
from the true solution by narrowing down the search space. As
a result, the method becomes not only more accurate but also
more robust, being able to cope with signals containing high
noise levels. The better accuracy provided by SSR can be
explained by a more accurate fitting of the data, as shown in
Figure 5. The proposed method outperforms other quantifica-
tion methods even in the presence of sharp spatial features, as
is shown in Figure 7 and Table 1. The higher SSIM values pro-
vided by SSR confirm objectively that the metabolic maps
obtained by SSR are closer to the ground truth than the maps
from AQSES and AQSES-MRSI.
Experiments with in vivo data show that the proposed method
provides less noisy spatial metabolite distributions. This leads to
better contoured metabolite maps. In addition, overlapping
peaks (e.g. Cho and Cr, with respective resonance frequencies
at 3.2 and 3.0 ppm) and metabolites present at relatively low
concentrations (e.g. lactate) can be better estimated (Fig. 12).
The good performance of the method can be explained by the
ℓ1 -norm regularization, which leads to soft thresholding of the
wavelet coefficients. The wavelet thresholding acts a non-linear
low-pass filter in the wavelet domain, where most image infor-
mation is contained in the few largest wavelet coefficients, while
the noise is uniformly spread out across all coefficients. Thus
thresholding mostly affects the noise rather than the signal.
The risk of missing spatial features of the smoothing filters is
alleviated by wavelets, which preserve image sharpness. Another
interesting property is that, even if we focus on the use of the ℓ1 -
norm in this manuscript, the method presented is not restricted
to this case. Other ℓp -norms (for 1 ≤ p) could be considered,
since the method can cope with any convex penalty. Therefore,
the regularization imposed on the spectral and spatial dimen-
sions can be different. For example, it might be interesting to
exploit the sparsity of the spectral dimension in combination
with a spatial smoothness prior, to quantify MRSI data from a ho-
mogeneous region. It is interesting to note that the use of an av-
eraged metabolite basis set could limit the performance of the
method in the case of high variances between voxels. However,
this limitation is true for any method assuming smooth spatial
variations. Methods able to handle a different metabolite basis
for each voxel will be analyzed in future studies. Interestingly,
the proposed method requires tuning only two parameters,
which give weights to the two regularization terms and can be
estimated automatically from the data (39). This facilitates the
Figure 12. Nine adjacent voxels from a patient with a brain tumour (Gliobastoma Multiforme) and the corresponding AQSES, AQSES-MRSI and SSR fits.
Cr and Lac peaks are erroneously fitted by the voxel-wise approach (AQSES) in many voxels. AQSES-MRSI clearly improves the quality of the fits, but Cr
and Lac are still not well captured. SSR is able to fit all the spectra correctly.
necessary automation of the quantification process in order to
make MRSI not only appealing but feasible in the clinical setting.
The method presented here can be extended to incorporate 3D
spatial information by using a 3D wavelet operator. This makes it
especially attractive in view of the increasing interest in high-
resolution 3D MRSI data, where the low SNR is a main limiting
factor.
CONCLUSIONS
A new method combining spatial and spectral regularizations in
the wavelet domain to improve MRSI data quantification has
been presented. It benefits from the combination of using a basis
of metabolite profiles and incorporating spectral and spatial con-
straints simultaneously. In contrast to previous approaches, the
suggested method combines two regularization terms to favour
solutions with specific properties in both spatial and spectral di-
mensions. Note that the spectral parameters are not restricted
to having spatially smooth variations. The method allows the
use of other priors promoting properties such as the sparsity of
the MRSI spectra in the wavelet domain. Experiments on syn-
thetic data clearly demonstrated some significant improvements
in quantification accuracy and robustness by using the proposed
spatial–spectral regularization. Experiments on in vivo data
showed well-contoured metabolite maps that can be used to de-
fine more targeted and more individualized treatments (1,2,42).
In addition, the presented method was able to correctly quantify
metabolites that are missed by other methods due to the
presence of noise or nuisance components, as has been shown
for the case of lactate. This is especially relevant for the quantifi-
cation of metabolites present in low concentrations. Dependence
on only two hyperparameters and the use of a fast proximal
algorithm that allows parallel computations facilitate the automa-
tion of the presented method, which is crucial for the acceptance
of any quantification method applicable to routine clinical imple-
mentation. Future work includes the extension of the proposed
method to incorporate 3D spatial information available from 3D
MRSI data and validation with high spatial resolution MRSI
images, where the low signal-to-noise ratio is a major limitation.
The integration of an automatic hyperparameter estimation
method is also an interesting prospect. Furthermore, the pro-
posed method can be extended to incorporate more sophisti-
cated priors, such as tissue distributions and anatomical
structures extracted from companion MRI images.
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APPENDIX
OPTIMIZATION PROCEDURE
This appendix details the optimization procedure used to minimize the criterion in (9). The algorithm used for the minimization is the
simultaneous direction method of multipliers (34) and is based on the concept of proximity operators (33). In what follows, we recall
the definition of a proximity operator and provide the expressions for the proximity operators involved in our quantification problem.
Definition 1
(33) Let Γ0(χ) be the class of proper lower semicontinous convex functions from a separable real Hilbert space χ to ]∞, +∞] and let
ϕ∈Γ0(χ). For every x∈ χ, the function ϕ + ∥   x ∥ 2/2 achieves its infimum at a unique point denoted by proxϕx. The operator
proxϕ : χ→ χ is the proximity operator of ϕ.
In this work, as the observed data are complex-valued, the definition of proximity operators is extended to a class of convex functions
defined for complex-valued variables. For the function
Φ : ℂ R→   ∞;þ∞x↦φRe Re xð Þ½  þ φIm Im xð Þ½  (A1)
where φRe and φIm are functions in Γ0(ℝ
R) and Re(x) (respectively Im(x)) is the vector of the real parts (respectively imaginary parts) of
the component of x∈ R, the proximity operator is defined as
proxΦ : ℂ
R→Rx↦proxΦRe Re xð Þ½  þ proxΦIm Im xð Þ½  (A2)
Proximity operator of the data fidelity term
Based on the above definitions, and according to standard rules about the calculation of proximity operators ((43), Table 1), the prox-
imity operator of the data fidelity term J WLS is given by
proxJWLSA ¼ Id þ 2Ψ1
 1
HAþ 2Ψ1S  (A3)
Proximity operators of the regularization terms
Regarding the regularization terms, the proximity operator of Φpμ;α for every ξ∈ℂ is given by
proxΦpμ;α ξ ¼ sign ξð Þη (A4)
where η= ηRe + iηIm is the unique solution in ℂ+ to η+ pη
p 1α= |ξ μ|. If p= 1, this proximity operator simplifies as follows:
proxΦ1μ;α ξ ¼ sign Re ξ  μð Þ½ max Re ξ  μð Þj j  Re αð Þ; 0f g
þi sign Im ξ  μð Þ½ max Im ξ  μð Þj j  Im αð Þ; 0f g (A5)
By referring to the spatial and spectral regularization terms g1 and g2 in (7) and (8), it turns out that the proximity operator of the
regularization term can be obtained by calculating the proximity operator of Φpμ;α∘T and Φ
p
μ;α∘F . These operators can be calculated
based on ((34), Lemma 2.4), leading to proxΦpμ;α∘T ¼ T1∘proxΦpμ;α ∘T (similarly for proxΦpμ;α∘F ).
Based on the calculated proximity operators, the resulting algorithm for the minimization of the optimality criterion in (9) is described
below in Algorithm 1.
It is important to note that the computations in this algorithm can be performed in a parallel manner (steps 4–6 can be computed in
parallel for each i). In addition, the global convergence of the algorithm to an optimal solution to the minimization problem is guar-
anteed. The parameter γ is related to the convergence speed of the algorithm and has been chosen by cross-validation for each case
(34). The stopping parameter ϵ has been set to 10 6 and the algorithm normally converges in fewer than 50 iterations.
Algorithm 1 Simultaneous direction method of multipliers
Set γ> 0, ε∈]0, 1[, Yi,0∈M × R, Zi,0∈M × R, i∈ {1,…,N}, Q ¼ ∑Nn¼1HH (N= 3 in our case). Set n= 1.
1 : repeat
2 : Set Un ¼ Q1 ∑
N
i¼1
H Y i;n  Z i;n
 
3 : for i=1 to N do
4 : Set Si,n=HAn
5 : Calculate Y i;nþ1 ¼ proxγgi Si;n þ Z i;n
 
6 : Set Zi,n + 1 =Zi,n+ Si,n Yi,n + 1
7 : end for
8 : n← n+ 1
9 : until J Unð Þ  J Un1ð Þj j < ε
10 : return Û=Un.
